Miss Daniel Teshuva

Tel Aviv (Israel)

Follow

Contributor content

The gut-heart axis: fecal microbiome shifts following SGLT2 inhibitor initiation in heart failure - a pilot study

Presentation

The gut-heart axis: fecal microbiome shifts following SGLT2 inhibitor initiation in heart failure - a pilot study

ESC 365 is supported by

novartis

Explore sponsored resources